Australian company Zifam Pinnacle Pty Ltd, which markets Facia in Australia, and Contract Manufacturing & Packaging Services Pty Ltd (CMPS), which manufactures Facia products, are both featured on the packaging of the Facia Premium capsules for sale in Asia
View details Anti-Aging & Longevity GHK-Cu GHK-Cu is a naturally occurring copper-binding tripeptide studied for its role in molecular signaling, matrix remodeling, and pathway dynamics

How the cagrilintide + tirzepatide stack compares Feature Components Cagrilintide + Tirzepatide Cagrilintide + Tirzepatide CagriSema (Cag + Sema) Cagrilintide + Semaglutide Cagrilintide + Retatrutide Cagrilintide + Retatrutide Feature Receptor coverage Cagrilintide + Tirzepatide AMY + GLP-1R + GIPR (3 families) CagriSema (Cag + Sema) AMY + GLP-1R (2 families) Cagrilintide + Retatrutide AMY + GLP-1R + GIPR + GCGR (4 families) Feature Combination clinical data Cagrilintide + Tirzepatide Preclinical only (Valdecantos 2024) CagriSema (Cag + Sema) Phase 3 REDEFINE-1: ~22.7% at 68 weeks Cagrilintide + Retatrutide None (fully speculative) Feature Best monotherapy result Cagrilintide + Tirzepatide Tirzepatide: 25.5% at 84 weeks CagriSema (Cag + Sema) Semaglutide: ~14.9% at 68 weeks Cagrilintide + Retatrutide Retatrutide: 28.7% at 68 weeks Feature GIP receptor Cagrilintide + Tirzepatide Yes (tirzepatide) CagriSema (Cag + Sema) No Cagrilintide + Retatrutide Yes (retatrutide) Feature Glucagon receptor Cagrilintide + Tirzepatide No CagriSema (Cag + Sema) No Cagrilintide + Retatrutide Yes (retatrutide) Feature Dysesthesia risk Cagrilintide + Tirzepatide No CagriSema (Cag + Sema) No Cagrilintide + Retatrutide Yes (retatrutide) Feature FDA-approved component Cagrilintide + Tirzepatide Yes (tirzepatide as Mounjaro / Zepbound) CagriSema (Cag + Sema) Semaglutide approved

Materials and methods Strains and culture conditions Yeasts were maintained and grown either in YPD broth [1% yeast extract (Oxoid), 2% bacteriological peptone (Oxoid), 2% D-glucose], or in YNB broth [0.69% yeast nitrogen base without amino acids (Formedium), 2% D-glucose] supplemented as required with amino acids, uracil, 5-FOA (Melford), D-histidine (Sigma) or reduced GSH (Sigma)
The BPC-157 + TB-500 blend is a 1:1 formulation at standard research doses